Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-26T16:14:38.340Z Has data issue: false hasContentIssue false
  • English
  • Français

Lithium-associated clinical hypothyroidism

Prevalence and risk factors

Published online by Cambridge University Press:  31 January 2018

Ann M. Johnston  and
John M. Eagles
Ann M. Johnston*
Affiliation:
Psychiatric Unit, Hairmyres Hospital, East Kilbride, Lanarkshire
John M. Eagles
Affiliation:
Royal Cornhill Hospital, Aberdeen
*
Ann M. Johnston, Consultant Psychiatrist. Psychiatric Unit, Hairmyres Hospital, Eaglesham Road, East Kilbride, Lanarkshire G75 8RG
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Rates of, and risk factors for, lithium-associated clinical hypothyroidism are uncertain.

Aims

To determine prevalence of and risk factors for clinical hypothyroidism in patients treated with lithium carbonate.

Method

Retrospective case-note review of 718 patients who had undergone serum lithium estimation during a 15-month period. Patients on thyroxine had a more detailed review.

Results

The prevalence of clinical hypothyroidism during lithium treatment was 10.4%. The main risk factor was female gender (women 14% v. men 4.5%). Women were at highest risk during the first two years of lithium treatment, and women starting lithium aged 40–59 years had the greatest prevalence (> 20%). No equivalent risk factors emerged in men, although, like women, their prevalence of hypothyroidism was substantially higher than community rates.

Conclusions

The high rates of clinical hypothyroidism identified may call for a review of the drug information given to women, particularly to those starting lithium in middle age. Consideration should be given to screening for thyroid antibodies before treatment in high-risk cases. Monitoring of thyroid function should take into account gender, age and stage of lithium treatment.

Type
Papers
Information
The British Journal of Psychiatry , Volume 175 , Issue 4 , October 1999 , pp. 336 - 339
Copyright
Copyright © 1999 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Declaration of interest

None.

References

Bland, J. M. & Altman, D. G. (1998) Survival probabilities (the Kaplan-Meier method). British Medical Journal, 317, 1572.CrossRefGoogle ScholarPubMed
Bocchetta, A., Cherchi, A., Loveselli, A., et al (1996) Six-year follow-up of thyroid function during lithium treatment. Acta Psychiatrica Scandinavica, 94, 45–48.CrossRefGoogle ScholarPubMed
Calabrese, J. R., GuHedge, A. D., Hahn, K., et al (1985) Autoimmune thyroiditis in manic-depressive patients treated with lithium. American Journal of Psychiatry 142, 1318–1321.Google ScholarPubMed
Cowdry, R. W., Wehr, T. A. & Zis, A. P. (1983) Thyroid abnormalities associated with rapid-cycling bipolar illness. Archives of General Psychiatry, 40, 414–420.CrossRefGoogle ScholarPubMed
Ferrier, I. N., Tyrer, S. P. & Bell, A. J. (1995) Lithium therapy. Advances in Psychiatric Treatment, 1, 102–110.CrossRefGoogle Scholar
Goodwin, F. K. (1990) Effect of long-term lithium on organs and systems. In Manic Depressive Illness (eds Goodwin, F. K. & Jamison, K. R.), pp. 702–704. New York: Oxford University Press.Google Scholar
Hickie, I., Bannett, B., Mitchell, P., et al (1996) Clinical and subclinical hypothyroidism in patients with chronic and treatment-resistant depression. Australian and New Zealand Journal of Psychiatry 30, 246–252.Google Scholar
Jefferson, J. W. (1990) Lithium: the present and the future. Journal of Clinical Psychiatry, 51 (suppl. 8), 4–8.Google ScholarPubMed
Leibenluft, E. (1996) Women with bipolar illness: clinical and research issues. American Journal of Psychiatry 153, 163–173.Google ScholarPubMed
Luby, E. D., Schwartz, D. & Rosenbaum, H. (1971) Lithium-carbonate-induced myxedema. Journal of the American Medical Association, 218, 1298–1299.Google Scholar
Maarbjerg, K., Vestergaard, P. & Schou, M. (1987) Changes in serum thyroid stimulating hormone (TSH) during prolonged lithium treatment. Acta Psychiatrica Scandinavica, 75, 217–221.CrossRefGoogle ScholarPubMed
Monzani, F., Pruneti, C. A., De Negri, F., et al (1991) Preclinical hypothyroidism: early involvement of memory function, behavioral responsiveness and myocardial contractility. Minerva Endocrinobgica, 16, 113–118.Google Scholar
Schou, M., Amisden, A., Jensen, S. E., et al (1968) Occurrence at goitre during lithium treatment. British Medical Journal, iii, 710–713.Google Scholar
Shelley, R. (1995) Affective disorders: 2. Lithium. In Seminars in Clinial Psychopharmacology (ed. King, D. J.), pp. 193–223. London: Gaskell.Google Scholar
Tunbridge, W. M. G., Evered, D. C., Hall, R., et al (1977) The spectrum of thyroid disease in a community: the Whickham Survey. Clinical Endocrinology 7, 481–493.CrossRefGoogle Scholar
Vanderpump, M. P. J., Tunbridge, W. M. G., French, J. M., et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology 43, 55–68.Google Scholar
Weetman, A. P. (1997) Hypothyroidism screening and subclinical disease. British Medical Journal, 314, 1175–1178.CrossRefGoogle ScholarPubMed
Yassa, R., Saunders, A., Nastase, C., et al (1988) Lithium-induced thyroid disorders: a prevalence study. Journal of Clinical Psychiatry, 49, 14–16.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.